Gleamer nabs $29.5M in funding
AI software developer Gleamer has raised $29.5 million in a Series B funding round.
AI software developer Gleamer has raised $29.5 million in a Series B funding round.
One-fifth of all technical leaders in the healthcare and life sciences industries report over 300% growth in budgets allocated for generative AI projects.
Juan Lavista Ferres, head of Microsoft’s AI for Good Lab, sat down with MobiHealthNews to discuss his book on ethically using AI to impact humanity…
Smart Reporting secures €23M in Series C funding led by TVM Capital Life Science and Bayern Kapital.
Digital health is poised to revolutionize the field of oncology, offering innovative solutions that enhance diagnostics, treatment, and patient care. This comprehensive review delves into…
Following incubation with HCA Healthcare EDs, Augmedix announces the general availability of Augmedix Go in emergency departments SAN FRANCISCO,……
Entering China’s healthcare market is becoming steadily more attractive for foreign investors. We discuss key prospects & regulatory limits.
“New study reveals hospital-acquired antimicrobial-resistant infections remain 12% above pre-pandemic levels, with a 32% increase during COVID-19. Carbapenem-re
Regulators have been pursuing more enforcement actions against health applications sharing consumers’ data. Friday’s final rule should give those actions more heft.
Digital Health Records: Speaking to the reporters at the NHM state headquarters here in Agartala, Das said, “Each of the healthcare professionals, pharmacies, and labs…
Built by Manoj Sanker and Pratyusha Pareddy, NemoCare Raksha is a wearable device that monitors vital parameters of a newborn and helps nurses and doctors…